Key Takeaways A 2026 study in Scientific Reports followed 49 patients with steroid-resistant GvHD treated with Wharton’s jelly MSCs at four hospitals in Spain. At day 28, 71.4% of patients responded to treatment. One-year survival reached 55.1%. Batches that scored above 70% on a potency test produced far better outcomes,
Key Takeaways Hypoxic brain injury is caused by reduced oxygen; anoxic brain injury by a complete stop. Both damage the same brain tissue but anoxic injuries tend to be more severe. Stem cell therapy supports recovery in both by releasing neurotrophic factors, reducing inflammation, and providing an environment for surviving
Key Takeaways Researchers at MUSC report that engineered mesenchymal stem cells reversed new-onset type 1 diabetes in mice, pointing to the disease’s immune response rather than just its symptoms. The cells were modified to overexpress a protein called alpha-1 antitrypsin, which calmed the autoimmune attack and protected insulin producing beta
Key Takeaways Stem cell therapy can slow cellular aging by targeting the immune system dysfunction and chronic inflammation that drive the aging process at the cellular level. Growth factors released by mesenchymal stem cells (MSCs) support boosting collagen, repairing damaged tissue, and improving skin quality from within. Findings show improvements
Key Takeaways The realistic goals of stem cell therapy for MS are slowing disease activity, reducing fatigue, and improving mobility, not reversing all past damage. Mesenchymal stem cells (MSCs) calm the immune system and protect nerve fibers. Hematopoietic stem cell transplant (HSCT) goes further, aiming to reset the immune system
Quick Summary A 2026 Nature study (MATCH trial) shows autologous macrophage therapy may improve transplant‑free survival in cirrhosis. After 4 years, ~70% of treated patients were alive without liver transplant vs. ~40% in standard care. The treatment uses the patient’s own immune cells (macrophages) to reduce inflammation and support repair.
Quick Summary Stem cell therapy is making measured progress toward treating age-related diseases like vision loss, frailty, and Parkinson’s, but broad age reversal remains unproven. Recent clinical trials show improved mobility in frailty patients, while Parkinson’s and vision repair trials aim to replace specific damaged cells. However, safety risks persist,
Quick Summary Mesenchymal stem cell (MSC) therapy for IBD (Crohn’s disease and ulcerative colitis) reduces inflammation, supports repair of damaged intestinal tissue, and helps balance immune response. It is not a replacement for biologics or steroids but may work alongside them. Clinical trials show improved gut symptoms and mucosal healing
Quick Summary Stem cell therapy for autism aims to reduce brain inflammation, modulate the immune system, and support nerve cell communication. Types of stem cells studied include umbilical cord derived cells, bone marrow stem cells, and umbilical cord blood cells. Early clinical trials show potential improvements in social interaction and
Quick Summary Stem cell therapy for Alzheimer’s uses mesenchymal stem cells (MSCs), neural stem cells (NSCs), or induced pluripotent stem cells (iPSCs) to repair damaged brain cells, reduce inflammation, and support the central nervous system. Early-stage patients may see improved memory and slower decline, but treatment is not yet a
